Optellum Obtains CE Mark for Its Early Lung Cancer Diagnosis AI Technology

Oxford, UK-based Optellum has obtained a CE mark for its Virtual Nodule Clinic, a clinical decision-support software application that helps clinicians identify patients with suspicious lung nodules that may be cancerous.

The artificial intelligence (AI)-based image analysis software can be used to ensure that patients are treated before the disease has metastasized, increasing their chance of survival.

The software, which received the FDA’s 510(k) clearance in early 2021, is being used in several U.S. hospitals, including Vanderbilt University Medical Center, the University of Mississippi Medical Center and Atrium Wake Forest Baptist.